Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study - Wikidata - awgldk - TriplyDB

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

http://www.wikidata.org/entity/Q34469135

about

The safety of tocolytics used for the inhibition of preterm labour.A Phase 1 Randomized, Placebo-Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese Subjects.Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose-ranging study Assessing a composite end point for new tocolytics in clinical trials: Data from 4 US integrated delivery networks.Retosiban Prevents Stretch-Induced Human Myometrial Contractility and Delays Labor in Cynomolgus Monkeys.

P2860

Q38829657-33388FE2-DAA7-4852-BD23-7A99B9F59873 Q38832009-8AE5E3F8-E26E-4418-8F52-C79059A6E100 Q41195723-845CF81F-8517-472A-8C19-25E447178AD2 Q47190995-4B7C8AB4-CBA8-48C8-B99C-B4F3F14CE138 Q54131628-4690ACEB-79A1-4691-8EFA-73B1B91C325C

P2860

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

http://www.wikidata.org/entity/Q34469135

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@ast

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@en

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@nl

type

label

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@ast

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@en

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@nl

prefLabel

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@ast

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@en

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@nl

P1433

Q34469135-27B742DD-7610-4841-9737-AA0B9CB9B3E0

P1476

Q34469135-E2A4F2D8-AB6F-4094-B8BA-28DFFAB09562

P2093

Q34469135-1EEF04FE-26B4-4167-9904-4401520A416F

Q34469135-83A07E2C-11CF-4B7A-8420-E5FAA26401A7

Q34469135-869DBAFD-9FD3-459C-BF6E-FB206BD613C9

Q34469135-94CC02E4-A659-4858-BC52-EE402DB22ECA

Q34469135-AE171854-6C2F-483D-BF4F-0E7E3576F4E2

Q34469135-C1306777-1905-4917-A436-737BBFCE0B68

Q34469135-CC8BCB34-6F11-4896-8F02-881643EABDD0

Q34469135-EA1A712D-C4EB-4771-B23A-53A3DE059BF8

Q34469135-FAC77502-CA06-4392-8BAD-D05DB3958C81

P2860

Q34469135-0125EF8D-2341-496B-BFF6-5B7610AFD1B7

Q34469135-0D8BE7EB-9270-4C53-B349-AC94E5A140AD

Q34469135-0F70B99C-E2E7-4020-A553-F55D5E471567

Q34469135-0FBE38B6-23CC-42B5-ADE2-51FCD05A2E85

Q34469135-3D830ACC-9918-4629-9470-DB303D120764

Q34469135-4D0E0B5F-39B6-4105-A183-91984427E02D

Q34469135-65CBC483-C6F0-4727-B710-7619BA20B4BB

Q34469135-72188B4F-6D4A-497C-99C6-8E10C8B43A3C

Q34469135-7519AF88-BAFB-4D50-9A29-C74BC8737FD8

Q34469135-8CBD5A58-EA1C-45F4-83B1-08ED1AE0CD07

P304

Q34469135-FD31A742-DEB0-490D-A2E7-23F30E3863D2

P31

Q34469135-CB75C0F3-AA2D-4B64-981F-65C7B17AA2BF

P356

Q34469135-EBD91548-4395-48DA-99C9-F50AD474B7C8

P407

Q34469135-6AD0899F-37F6-4DF8-84DC-3B75FC75DC62

P433

Q34469135-9BCD7D38-98D7-4C3A-A92D-4C6346D1DE66

P478

Q34469135-C94BE09D-EA64-476A-A836-3193A4748F43

P577

Q34469135-3F53E314-6239-4265-9471-4E6C9A03F93D

P698

Q34469135-A83A5887-F55E-4830-A1C8-C051A7525E3F

P932

Q34469135-52763430-DA78-4229-8B7F-C3E711F6F1E7

P356

P1433

British Journal of Clinical Pharmacology

P1476

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study

@en

P2093

Brendt Stier

http://www.w3.org/2001/XMLSchema#string

Guillermo Valenzuela

http://www.w3.org/2001/XMLSchema#string

Hugh Miller

http://www.w3.org/2001/XMLSchema#string

Jerry Snidow

http://www.w3.org/2001/XMLSchema#string

Kathleen J Beach

http://www.w3.org/2001/XMLSchema#string

Marcy Powell

http://www.w3.org/2001/XMLSchema#string

Michael J Fossler

http://www.w3.org/2001/XMLSchema#string

Steven Thornton

http://www.w3.org/2001/XMLSchema#string

Timothy H Montague

http://www.w3.org/2001/XMLSchema#string

P2860

Betamimetics for inhibiting preterm labour

Betamimetics for inhibiting preterm labour

Efficacy of maintenance therapy after acute tocolysis: a meta-analysis.

Tocolytics for preterm labor: a systematic review.

Guide to Receptors and Channels (GRAC), 5th edition.

Tocolytic therapy for preterm delivery: systematic review and network meta-analysis

Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat.

The discovery of GSK221149A: a potent and selective oxytocin antagonist.

An overview of mortality and sequelae of preterm birth from infancy to adulthood.

Epidemiology of preterm birth

P304

740-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12646

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25819462

http://www.w3.org/2001/XMLSchema#string

P932

4594710

http://www.w3.org/2001/XMLSchema#string